Literature DB >> 3292396

Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation.

D E Jenne1, J Tschopp.   

Abstract

The cytolytic potential of T effector cells appears to be intimately related to the presence of proteins stored in specialized cytoplasmic granules. A striking biological property of isolated granules is their lytic activity for a variety of target cells in a nonrestricted manner. Proteins contained within these granules of CTLs are specifically released upon target cell recognition. We have isolated and characterized six granule-associated proteins in two murine CTL lines in addition to the pore-forming and target membrane-disrupting perforin. Six full length cDNA clones have been identified in a CTL-specific cDNA expression library which code for the granule-associated serine esterases, designated as granzymes A to F. Granzymes A and B represent the genuine proteins encoded by the H factor/CTLA-3 cDNA and the CTLA-1/CCPI cDNA, respectively. The covalent amino acid structures of all six granzymes show the hallmarks for serine proteases and are highly related to that of rat mast cell protease I and II and cathepsin G, which have been found in granules of mast cells and neutrophilic granulocytes, respectively. The primary translation products are processed by removal of a hydrophobic signal peptide and a two residue-long propeptide at the amino-terminus. Immuno-electron microscopy shows that granzymes and perforin are stored together within secretory granules of CTLs. Simultaneous release of at least two of these granzymes has been observed during degranulation of a murine CTL line by anti-T3 antibodies. The biological role, particularly the proteolytic events elicited by granzyme A and other granzymes in the context of target cell recognition, are not known at present. It is unlikely that they form a proteolytic activation cascade together with pore-forming proteins analogous to the complement system. The strictly regulated secretion of granzymes and the lack of measurable enzymatic activity in the case of granzymes B, C, E and F towards a variety of synthetic substrates suggest a highly specific function for each of them.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292396     DOI: 10.1111/j.1600-065x.1988.tb00749.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  61 in total

1.  Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis.

Authors:  D Zhang; P J Beresford; A H Greenberg; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

Review 2.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena.

Authors:  K T Miyasaki; A L Bodeau
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

4.  Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp.

Authors:  J A Trapani
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

Review 5.  Protease signalling: the cutting edge.

Authors:  Boris Turk; Dušan Turk; Vito Turk
Journal:  EMBO J       Date:  2012-02-24       Impact factor: 11.598

Review 6.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

7.  Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them.

Authors:  P J Beresford; C M Kam; J C Powers; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

8.  Structure of granzyme C reveals an unusual mechanism of protease autoinhibition.

Authors:  Dion Kaiserman; Ashley M Buckle; Petra Van Damme; James A Irving; Ruby H P Law; Antony Y Matthews; Tanya Bashtannyk-Puhalovich; Chris Langendorf; Philip Thompson; Joël Vandekerckhove; Kris Gevaert; James C Whisstock; Phillip I Bird
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-19       Impact factor: 11.205

9.  Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin.

Authors:  Daniel S John; Julia Aschenbach; Burkhard Krüger; Matthias Sendler; F Ulrich Weiss; Julia Mayerle; Markus M Lerch; Ali A Aghdassi
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

10.  Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena.

Authors:  K T Miyasaki; A L Bodeau; J Pohl; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.